21 C.F.R. § 862.3645

Current through November 30, 2024
Section 862.3645 - Neuroleptic drugs radioreceptor assay test system
(a)Identification. A neuroleptic drugs radioceptor assay test system is a device intended to measure in serum or plasma the dopamine receptor blocking activity of neuroleptic drugs and their active metabolites. A neuroleptic drug has anti-psychotic action affecting principally psychomotor activity, is generally without hypnotic effects, and is a tranquilizer. Measurements obtained by this device are used to aid in determining whether a patient is taking the prescribed dosage level of such drugs.
(b)Classification. Class II.

21 C.F.R. § 862.3645